Major S. Korea Pharmas Meet To Resolve Issue Of Bribing Doctors
This article was originally published in PharmAsia News
Executive Summary
S. Korea's leading pharmaceutical companies have begun meeting to resolve the issue of companies offering bribes or other favors to physicians and pharmacists to promote their products. The Korea Pharmaceutical Manufacturers Association said 10 major South Korean drug makers discussed the matter. Among those reported to have been represented were Daewoong, Dong-A Pharmaceutical, Hanmi Pharmaceutical and Yuhan. The move comes in the wake of government threats to prosecute several drug firms for offering bribes. (Click here for more